Recent Repros (NASDAQ:RPRX) FDA development indicates a good time to buy in April 9, 2015 Jacob Maslow
Look into OvaScience (NASDAQ:OVAS) for a lucrative biotech speculative buy April 8, 2015 Jacob Maslow